These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19845736)

  • 1. Severe and disabling constipation: an adverse effect of pregabalin.
    Kamel JT; D'Souza WJ; Cook MJ
    Epilepsia; 2010 Jun; 51(6):1094-6. PubMed ID: 19845736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin in the treatment of chronic migraine: an open-label study.
    Calandre EP; Garcia-Leiva JM; Rico-Villademoros F; Vilchez JS; Rodriguez-Lopez CM
    Clin Neuropharmacol; 2010; 33(1):35-9. PubMed ID: 19935409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin: preliminary experience in intractable childhood epilepsy.
    Jan MM; Zuberi SA; Alsaihati BA
    Pediatr Neurol; 2009 May; 40(5):347-50. PubMed ID: 19380070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin for alcohol dependence: a critical review of the literature.
    Guglielmo R; Martinotti G; Clerici M; Janiri L
    Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability.
    Huber B; Bocchicchio M; Feuerbaum E; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Wilking E; Seidel M
    Epilepsy Behav; 2008 Aug; 13(2):397-401. PubMed ID: 18554985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for peripheral neuropathic pain.
    Hadj Tahar A
    Issues Emerg Health Technol; 2005 Mar; (67):1-4. PubMed ID: 15806748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R
    Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pregabalin on preoperative anxiety and sedation levels: a dose-ranging study.
    White PF; Tufanogullari B; Taylor J; Klein K
    Anesth Analg; 2009 Apr; 108(4):1140-5. PubMed ID: 19299776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling longitudinal daily seizure frequency data from pregabalin add-on treatment.
    Ahn JE; Plan EL; Karlsson MO; Miller R
    J Clin Pharmacol; 2012 Jun; 52(6):880-92. PubMed ID: 21646441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy.
    Modur PN; Milteer WE
    Epilepsy Behav; 2008 Oct; 13(3):554-6. PubMed ID: 18579443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre.
    Yuen AW; Singh R; Bell GS; Bhattacharjee A; Neligan A; Heaney DC; Duncan JS; Sander JW
    Epilepsy Res; 2009 Dec; 87(2-3):120-3. PubMed ID: 19734010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.